| Financial Year |
March 31 2023 |
| Monetary Funds |
844,113,301.72 |
| Held-for-trading Financial Assets |
4,067,563.50 |
| Notes Receivable |
141,978,320.01 |
| Accounts Receivable |
746,858,944.57 |
| Advances to Suppliers |
17,812,275.95 |
| Other Receivables |
162,191,136.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
140,607,037.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
49,798,852.23 |
| Total Current Assets |
3,302,072,390.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
112,051,521.00 |
| Investment Properties |
-- |
| Fixed Assetes |
1,083,483,925.48 |
| Under-construction Projects |
9,980,128.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
118,752,791.12 |
| R&D expenses |
2,045,652.83 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,009,533.71 |
| Deferred Income Tax Assets |
335,958,881.06 |
| Other Non-Current Assets |
1,040,618,273.26 |
| Sub-Total of Non-Current Assets |
2,769,312,302.23 |
| Total Assets |
6,071,384,692.23 |
| Short-Term Loans |
457,172,250.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,000,963,040.63 |
| Accounts Payable |
1,669,936,045.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,624,322.37 |
| Taxes Payable |
8,831,112.41 |
| Interest Payable |
-- |
| Dividend Payable |
10,397,485.70 |
| Other payables |
64,626,523.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,462,807.82 |
| Other Current Liabilities |
22,260,665.29 |
| Sub-Total of Current Liabilities |
3,448,220,051.69 |
| Long-term Loans |
138,571,624.16 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
669,990,773.35 |
| Deferred Income Tax Liabilities |
253,261,149.25 |
| Other Non-Current Liabilities |
23,601,217.36 |
| Sub-Total of Non-Current Liabilities |
1,154,695,752.23 |
| Total Liabilities |
4,602,915,803.92 |
| Paid-In Capital(Or Share Stock) |
844,957,867.00 |
| Capital Surplus |
976,793,272.54 |
| Surplus Reserve |
62,690,366.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-574,254,200.55 |
| Minority Stockholder's Interest |
158,281,583.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,310,187,305.20 |
| Owner's Equity（Stockholder's Equity） |
1,468,468,888.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,071,384,692.23 |
